More than 23.5 million people are suffering from an autoimmune disease.
Autoimmune diseases occur when your immune system is unable to distinguish between your own cells and foreign cells and mistakenly attacks normal cells. There are more than 100 types of autoimmune diseases.
Organ-specific autoimmune diseases: primary biliary cirrhosis (PBC), autoimmune hepatitis, type 1 diabetes, Graves disease, Hashimoto thyroiditis, and Addison disease. Systemic autoimmune diseases: multiple sclerosis (MS), myasthenia gravis (MG), psoriasis, rheumatoid arthritis (RA), and systemic lupus erythematosus (SLE).
The symptoms of autoimmune diseases differ among individual diseases. Common symptoms include fatigue, joint pain and swelling, abdominal pain or digestive issues, skin rash, recurring fever, and swollen glands.
Supporting a full range of antibody development and cell therapy development services to advance the
discovery of novel therapies for autoimmune diseases.
With the understanding of the mechanism of autoimmunity, it is now possible to develop mAbs targeting every single step of the immune process from the activation of T lymphocytes in lymph nodes to T cell differentiation and cytokine production. Creative Biolabs supports a series of incomparable one-stop antibody development services to advance the discovery of novel therapies for autoimmune diseases.
Bispecific antibodies offer attractive new opportunities for the design of novel therapeutics for autoimmune diseases which are regulated by diverse cytokines. Creative Biolabs is focused on developing an effective cell therapy for autoimmune diseases by harnessing our extensive expertise.
Several T-cell subsets have been identified to have the ability to inhibit immune responses to a variety of self-antigens and nonself-antigens, such as natural regulatory T (Treg) cells, natural killer T cells, and myelomonocytes. Supporting by the experienced leadership team and powerful technical platforms, we provide a full range of cell therapy development services for global clients.
We are committed to becoming your best partner to develop novel and effective drugs for autoimmune diseases.